-
OpenAI Calls a ‘Code Red’ + Which Model Should I Use? + The Hard Fork Review of Slop
“For OpenAI to realize its ambitions, it is not going to be enough for them to make a model that is as good as Gemini 3. They need to be able to leapfrog it again.”
-
Chuck Kesey, Probiotic Yogurt Pioneer, Dies at 87
The younger brother of Ken Kesey, the novelist and counterculture luminary, he turned a defunct creamery into what is now Nancy’s Probiotic Foods.
-
Olivia Nuzzi and Vanity Fair Will Part Ways
Condé Nast, the magazine’s parent company, said her contract would expire at the end of the year.
-
Lots of Oil, Little Production: What to Know About Venezuelan Energy
The South American country increasingly at odds with the Trump administration has the world’s largest oil reserves.
-
Netflix Changes Course Again With Warner Bros. Deal
The streaming giant has changed its strategy many times over the years. But the decision to get deeply into theatrical releases may be the most startling yet.
-
CNN Is Excluded From Netflix’s Warner Bros. Deal for Now
The prospect of Paramount’s buying Warner Bros. Discovery had led CNN journalists to wonder if the channel may be combined with CBS News. Instead, CNN will remain in a separate corporate entity.
-
Running Out of Time, Republicans in Congress Still Lack a Health Plan
Top Republicans have said they want to produce a proposal in short order to counter Democrats pressing for an extension of health care subsidies. They have not gotten far.
-
Trump’s Security Strategy Focuses on Profit, Not Spreading Democracy
President Trump’s new National Security Strategy describes a country that is focused on doing business and reducing migration while avoiding passing judgment on authoritarians.
-
The Supreme Court, Once Wary of Partisan Gerrymandering, Goes All In
The court’s conservative majority said that Texas’ asserted political motives justified letting the state use voting maps meant to disadvantage Democrats in the midterms.
-
As Bongino Celebrates Arrest in Pipe Bomb Case, Others on the Right Remain Skeptical
Some activists have lashed out, in a reprise of the backlash over the unsuccessful effort by Trump appointees to shut down the Epstein investigation.